Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis

Brain Research

Volumn 721, Issue 1-2, 1996, Pages 196-203

  Wagstaff, John D ^a,b   Gibb, James W ^a   Hanson, Glen R ^a  

^a UNIVERSITY OF UTAH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antipsychotic; Dopamine; Extrapyramidal; Limbic; Microdialysis; Neuropeptide; Neurotensin

Indexed keywords

DOPAMINE 2 RECEPTOR; NEUROTENSIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; POTASSIUM; QUINPIROLE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HORMONE RELEASE; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; ANIMAL; BIOSYNTHESIS; CAUDATE NUCLEUS; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTROSTIMULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOSTRIATUM; PERFUSION; PHYSIOLOGY; RADIOIMMUNOASSAY; SPRAGUE DAWLEY RAT;

ANIMALS; CAUDATE NUCLEUS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; NEOSTRIATUM; NEUROTENSIN; NUCLEUS ACCUMBENS; PERFUSION; POTASSIUM; QUINPIROLE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 0029665556     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00132-1     Document Type: Article

References (41)

1. Bean, A.J., During, M.J., Deutch, A.Y. and Roth, R.H., Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies. Neuroscience, 9 (1989) 4430-4438.
2. Bean, A.J., During, M.J. and Roth, R.H., Effects of autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortex, Neurosci. Lett., 108 (1990) 143-148.
3. Blaha, C.D., Coury, H.C., Fibiger, H.C. and Phillips, A.G., Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross validation using in vivo voltammetry and microdialysis, Neuroscience, 34 (1990) 699-705.
4. Blaha, C.D. and Phillips, A.G., Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens, Neuroscience, 49 (1992) 867-877.
5. Booze, R.M. and Wallace, D.R., Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride, Synapse, 19 (1995) 1-13.
6. Bouthenet, M.L., Souil, E., Martres, M.-P., Sokoloff, P., Giros, B. and Schwartz, J.-C., Localization of dopamine D-3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D-2 receptor mRNA, Brain Res., 564 (1991) 203-219.
7. Brog, J.S. and Zahm, D.S., Morphology and Fos immunoreactivity reveal two subpopulations of striatal neurotensin neurons following acute 6-hydroxydopamine lesions and reserpine administration, Neuroscience, 65 (1995) 71-86.
8. Castel, M.-N., Morino, P. and Hokfelt, T., Modulation of the neurotensin striato-nigral pathway by D1 receptors, Neuroreport, 5 (1993) 281-284.
9. Castel, M.-N., Morino, P., Dagerlind, A. and Hokfelt, T., Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment, Eur. J. Neurosci., 6 (1993) 646-656.
10. Castel, M.-N., Morino, P., Nylander, I., Terenius, L. and Hokfelt, T., Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat, Eur. J. Pharmacol., 262 (1994) 1-10.
11. Deutch, A.Y. and Zahm, D.S., The current status of neurotensindopamine interactions: issues and speculations, Ann. N.Y. Acad. Sci., 668 (1992) 232.
12. Devine, D.P., Leone, P. and Wise, R.A., Striatal tissue preparation facilitates early sampling in microdialysis and reveals an index of neuronal damage, J. Neurochem., 61 (1993) 1246-1254.
13. Diaz, J., Lévesque, D., Griffon, N., Lammers, C.H., Martres, M.-P., Sokoloff, P. and Schwartz, J.-C., Opposing roles for dopamine D-2 and D-3 receptors on neurotensin mRNA expression in nucleus accumbens, Eur. J. Pharmacol., 6 (1994) 1384-1387.
14. Ervin, G.N., Birkemo, L.S., Nemeroff, C.B. and Prange, A.J., Neurotensin blocks certain amphetamine-induced behaviors, Nature, 291 (1981) 73-76.
15. Ford, A.P.D.W. and Marsden, C.A., In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat, Brain Res., 534 (1990) 243-250.
16. Frey, P., Lis, M. and Coward, D.M., Neurotensin concentrations in rat striatum and nucleus accumbens: further studies of their regulation, Neurochem. Int., 12 (1988) 33-38.
17. Gerfen, C.R., Engber, P.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, F.J.J. and Sibley, D.R., D1 and D2 dopamine receptor-regulated gene expression on striatonigral and striatopallidal neurons, Science, 250 (1990) 1429.
18. Govoni, S., Hong, J.S., Yang, H.Y.-T. and Costa, E., Increase of neurotensin content elicited by neuroleptics in the nucleus accumbens, J. Pharmacol. Exp. Ther., 215 (1980) 413-417.
19. Kalivas, P.W., Burgess, S.K., Nemeroff, C.B. and Prange, A.J., Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience, 8 (1983) 495-505.
20. Letter, A.A., Matsuda, L.A., Merchant, K.M., Gibb, J.W. and Hanson, G.R., Characterization of dopaminergic influence on striatal-nigral neurotensin systems. Brain Res., 422 (1987) 200-203.
21. Letter, A.A., Merchant, K.M., Gibb, J.W. and Hanson, G.R., Effect of methamphetamine on neurotensin concentrations in rat brain regions, J. Pharmacol. Exp. Ther., 241 (1987) 443-447.
22. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Nat. Acad. Sci. USA, 89 (1992) 8155-8159.
23. Maidment, N.T., Siddall, B.J., Rudolph, V.R., Erdelyi, E. and Evans, C.J., Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay, Neuroscience, 45 (1991) 81-93.
24. Merchant, K.M., Letter, A.A., Gibb, J.W. and Hanson, G.R., Changes in limbic neurotensin systems induced by dopaminergic drugs. Eur. J. Pharmacol., 153 (1988) 1-9.
25. Merchant, K.M., Bush, L.G., Gibb, J.W. and Hanson, G.R., Dopamine D-2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain, Brain Res., 500 (1989) 21-29.
26. Merchant, K.M., Gibb, J.W. and Hanson, G.R., Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and nucleus accumbens., Eur. J. Pharmacol., 160 (1989) 409-412.
27. Merchant, K.M., Miller, M.A., Ashleigh, E.A. and Dorsa, D.M., Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in the neostriatum of the rat brain, Brain Res., 540 (1991) 311-314.
28. Merchant, K.M., Dobner, P.R. and Dorsa, D.M., Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum, J. Neurosci., 12 (1992) 652-663.
29. Nemeroff, C.B., Bissette, G., Prange Jr., A.J., Loosen, P.T., Barlow, T.S. and Lipton, M.A., Neurotensin: Central nervous system effects of a hypothalamic peptide, Brain Res., 128 (1977) 485-496.
30. Nemeroff, C.B., Neurotensin: perchance an endogenous neuroleptic? Biol. Psychiat., 15 (1980) 283-302.
31. Nemeroff, C.B., Luttinger, D., Hernandez, D.E., Mailman, R.B., Mason, G.A., Davis, S.D., Widerlov, E., Frye, F.G.D., Kilts, C.D., Beaumont, K., Breese, G.R. and Prange, A.J., Jr., Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies, J. Pharmacol. Exp. Ther., 225 (1983) 337-345.
32. Nemeroff, C.B., The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia, Psychoneuroendocrinology, 11 (1986) 15-37.
33. Paxinos, P. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
34. Senger, B., Brog, J.S. and Zahm, D.S., Subsets of neurotensin-immunoreactive neurons in the rat striatal complex following antagonism of the dopamine D-2 receptor: an immunohistochemical double-labeling study using antibodies against Fos, Neuroscience, 57 (1993) 649-660.
35. Sirinathsinghji, D.J.S., Schuligoi, R., Heavens, R.P., Dixon, A., Iverson, S.D. and Hill, R.G., Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D-2 receptor antagonist, Neuroscience, 62 (1994) 407-423.
36. Sugimoto, T. and Mizuno, N., Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat, J. Comp. Neurol., 257 (1987) 383-395.
37. 5)-enkephalin and neurotensin content in the rat, Biochem. Pharmacol., 41 (1991) 1385-1391.
38. van Wimersma Greidanus, T.B., van Praag, M.C.G., Kalmann, R., Rinkel, G.J.E., Croiset, G., Hoeke, E.C., van Egmond, M.A.H. and Fekete, M., Behavioral effects of neurotensin, Ann. N. Y. Acad. Sci., 1982, 319-329.
39. Wagstaff, J.D., Gibb, J.W. and Hanson, G.R., Dopamine D-2 regulation of neurotensin release from striatum and nucleus accumbens as measured by microdialysis, Abst. Soc. Neurosci., 20 (1994) 1146.
40. Wagstaff, J.D., Bush, L.G., Gibb, J.W. and Hanson, G.R., Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity, Brain Res., 665 (1994) 237-244.
41. Yamada, I., Mizuta, H., Ogawa, K. and Tahara, T., Comparative pharmacokinetics of sulpiride and N-[(1-butyl-2-pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,3-dihydrobenzofuran-7- carboxamide hydrochloride, a new lipophilic substituted benzamide in rats, Chem. Pharm. Bull., 38 (1990) 2552-2555.